Literature DB >> 11999361

A pleural effusion caused by fibrous hematopoietic tumor successfully treated with prednisolone in a patient with agnogenic myeloid metaplasia with myelofibrosis.

Yasuo Hirayama1, Ryuzo Koyama, Tadanori Nagai, Takuya Matsunaga, l Katsuhisa Kogawa, Sumio Sakamaki, Yasuo Kokai, Yoshiro Niitsu.   

Abstract

A 46-year-old woman suffering from agnogenic myeloid metaplasia (AMM) since 1994 was being followed as an outpatient. In November 1999, she exhibited respiratory failure caused by massive pulmonary effusion, which was speculated to have been produced by chest tumors. A biopsy specimen revealed findings compatible with fibrous hematopoietic tumor (FHT): prominent fibroblasts and fibrosis with scantv megakaryocytes. Serum concentrations of transforming growth factor (TGF)-beta and platelet-derived growth factor (PDGF) were significantly higher than those of other cases of AMM without FHT. The effusion did not respond to administrations of various chemotherapeutic agents, but after prednisolone administration, the effusion disappeared and the tumors also diminished. TGF-beta and PDGF were the possible causes of FHT formation, and for such fibrotic extramedullary regions, the administration of prednisolone should be considered.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11999361     DOI: 10.1007/bf02982047

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  10 in total

1.  Myelofibrosis. Clinical, hematologic and pathologic study of 110 patients.

Authors:  B A BOURONCLE; C A DOAN
Journal:  Am J Med Sci       Date:  1962-06       Impact factor: 2.378

2.  [Successful high-dose methylprednisolone therapy in a patient with primary myelofibrosis].

Authors:  Y Matsukawa; E Ikeda; H Suguro; Y Iizuka; S Nishinarita; T Hayama; T Ohshima; S Sawada; T Horie
Journal:  Rinsho Ketsueki       Date:  1990-10

3.  Pleural effusion secondary to extramedullary haemopoiesis in a patient with idiopathic myelofibrosis responding to pleurodesis and hydroxyurea.

Authors:  S N Jowitt; D K Burke; H M Leggat; P S Lewis; R J Cryer
Journal:  Clin Lab Haematol       Date:  1997-12

4.  High-dose intravenous methylprednisolone for idiopathic myelofibrosis.

Authors:  S Ozsoylu
Journal:  Lancet       Date:  1988-04-02       Impact factor: 79.321

5.  Massive hemothorax associated with intrathoracic extramedullary hematopoiesis involving the pleura.

Authors:  J P Kupferschmid; D M Shahian; A G Villanueva
Journal:  Chest       Date:  1993-03       Impact factor: 9.410

6.  Ascites and pleural effusion secondary to extramedullary hematopoiesis.

Authors:  I Oren; A Goldman; N Haddad; Z Azzam; N Krivoy; G Alroy
Journal:  Am J Med Sci       Date:  1999-10       Impact factor: 2.378

7.  Transforming growth factor-beta1 (TGF-beta1) induces thrombopoietin from bone marrow stromal cells, which stimulates the expression of TGF-beta receptor on megakaryocytes and, in turn, renders them susceptible to suppression by TGF-beta itself with high specificity.

Authors:  S Sakamaki; Y Hirayama; T Matsunaga; H Kuroda; T Kusakabe; T Akiyama; Y Konuma; K Sasaki; N Tsuji; T Okamoto; M Kobune; K Kogawa; J Kato; R Takimoto; R Koyama; Y Niitsu
Journal:  Blood       Date:  1999-09-15       Impact factor: 22.113

8.  Bone growth and haemopoiesis: steroid reversible anaemia, myelofibrosis and increased bone formation in a child.

Authors:  L G Macdougall; J M Pettifor; J M Patel
Journal:  Br J Haematol       Date:  1987-05       Impact factor: 6.998

9.  Fibrous hematopoietic tumors arising in agnogenic myeloid metaplasia.

Authors:  E N Beckman; J S Oehrle
Journal:  Hum Pathol       Date:  1982-09       Impact factor: 3.466

10.  Immunoassay of platelet-derived growth factor in the blood of patients with diabetes mellitus.

Authors:  A A Harrison; P R Dunbar; T J Neale
Journal:  Diabetologia       Date:  1994-11       Impact factor: 10.122

  10 in total
  1 in total

1.  Nontuberculous mycobacterial infection in a patient with myelofibrosis: case report and concise review.

Authors:  Cesar Henriquez-Camacho; Pilar Martinez-Barranco; Maria Velasco; Paola Villafuerte-Gutierrez; Juan Losa
Journal:  Clin Case Rep       Date:  2015-04-09
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.